Huntleigh Advisors, Inc. Becton Dickinson & CO Transaction History
Huntleigh Advisors, Inc.
- $518 Billion
- Q2 2025
A detailed history of Huntleigh Advisors, Inc. transactions in Becton Dickinson & CO stock. As of the latest transaction made, Huntleigh Advisors, Inc. holds 2,938 shares of BDX stock, worth $555,370. This represents 0.1% of its overall portfolio holdings.
Number of Shares
2,938
Previous 2,979
1.38%
Holding current value
$555,370
Previous $682 Million
25.83%
% of portfolio
0.1%
Previous 0.16%
Shares
3 transactions
Others Institutions Holding BDX
# of Institutions
1,743Shares Held
259MCall Options Held
1.82MPut Options Held
696K-
Vanguard Group Inc Valley Forge, PA32.3MShares$6.11 Billion0.09% of portfolio
-
Black Rock Inc. New York, NY22.3MShares$4.21 Billion0.12% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD16.2MShares$3.06 Billion1.76% of portfolio
-
State Street Corp Boston, MA13.4MShares$2.54 Billion0.09% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD8.88MShares$1.68 Billion0.17% of portfolio
About BECTON DICKINSON & CO
- Ticker BDX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 285,195,008
- Market Cap $53.9B
- Description
- Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...